EUVIMEDOpdag EUVIMED
Randomisierte kontrollierte StudieStudienprotokollOpen access

Identifying Optimal Testing Modalities to Increase COVID-19 Testing Access in Baltimore, Maryland: Protocol for a Household Randomized Controlled Trial

Jessica Duchen iD, Alexandra K Mueller iD, Saifuddin Ahmed iD, Jamie Perin iD, Courtney Borsuk iD, Joshua Trowell iD, Kelly Lowensen iD, Steven Huettner iD, Andy Peytchev iD, Jason E Farley iD, Shruti H Mehta iD, Jacky M Jennings iD

JMIR Research Protocols · 2025

DOI: 10.2196/68600 ↗

At a glance

Randomisierte kontrollierte Studie in JMIR Research Protocols, 2025. Written by Jessica Duchen and 11 co-authors. Institution: Center for Child and Community Research, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, MD, United States. Major MEDLINE topics: COVID-19, COVID-19 Testing, Health Services Accessibility. 11 references. The full text is freely available in PubMed Central. Funded by: NIAID NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

The COVID-19 pandemic disproportionately affected low-income and racial and ethnic minority populations. Testing plays a critical role in disrupting disease transmission, but complex barriers prevent optimal testing access, particularly for Black and Latinx communities. There is limited evidence regarding the optimal testing modalities to increase testing access for these populations.

Objective

This study aimed to define the optimal COVID-19 testing modalities for maximizing testing acceptance, uptake, and timeliness of receipt of results.

Methods

The Community Collaboration to Combat COVID-19 (C-FORWARD) trial was a household randomized comparative effectiveness trial conducted in a representative sample of an urban population. Households across 653 census block groups were sampled using a probability proportional to size approach. The primary outcome was the completion of SARS-CoV-2 or COVID-19 testing within 30 days of randomization.

Results

Between February 2021 and December 2022, a total of 1083 individuals were enrolled, including 881 (81.35%) index participants and 202 (18.65%) household members. The mean age of participants was 51 (SD 18) years.Of the total sample, 43% (n=460) of participants identified as Black or African American, 48.6% (n=526) as White, and 9% (n=91) as other, including Asian, American Indian, Native Hawaiian or Pacific Islander, and multiple races; 4.8% (n=48) of participants identified as Hispanic or Latino. At the time of enrollment, 51.1% (n=553) were currently working either full time or part time, and 32.9% (n=342) of participants had an advanced degree. In total, 80% (n=809) of participants had been tested for COVID-19 previously, with 22.3% (n=179) reporting a prior positive test for COVID-19, and 86.8% (n=890) reporting receiving at least one COVID-19 vaccination before enrollment.

Conclusions

Data from the C-FORWARD trial will be used to address important questions regarding COVID-19 testing acceptance and uptake in an urban population. International Registered Report Identifier (IRRID) RR1-10.2196/68600

Subjects

MeSH terms (MEDLINE)

COVID-19COVID-19 TestingHealth Services AccessibilityHumansMiddle AgedMaleFemaleSARS-CoV-2BaltimoreAdultFamily CharacteristicsRandomized Controlled Trials as TopicPatient Acceptance of Health Care

Author keywords

SARS-CoV-2disease controlhealth disparitieshealth equityhealthcare accessinfectious diseasemobileurban health

Authors and institutions

  • Center for Child and Community Research, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, MD, United States.
  • Department of Population, Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
  • Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
  • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
  • Center for Infectious Disease and Nursing Innovation, Johns Hopkins School of Nursing, Baltimore, MD, United States.
  • Center for Survey Methodology, Survey Research Division, Research Triangle Institute International, Research Triangle Park, NC, United States.

ORCID profiles: Jessica Duchen, Alexandra K Mueller, Saifuddin Ahmed, Jamie Perin, Courtney Borsuk, Joshua Trowell, Kelly Lowensen, Steven Huettner, Andy Peytchev, Jason E Farley, Shruti H Mehta, Jacky M Jennings

Funding

  • NIAID NIH HHS

Cite

APA

Duchen, J., Mueller, A. K., Ahmed, S., Perin, J., Borsuk, C., Trowell, J., Lowensen, K., Huettner, S., Peytchev, A., Farley, J. E., Mehta, S. H., & Jennings, J. M. (2025). Identifying Optimal Testing Modalities to Increase COVID-19 Testing Access in Baltimore, Maryland: Protocol for a Household Randomized Controlled Trial. JMIR Research Protocols. https://doi.org/10.2196/68600

Vancouver

Duchen J, Mueller AK, Ahmed S, Perin J, Borsuk C, Trowell J, et al. Identifying Optimal Testing Modalities to Increase COVID-19 Testing Access in Baltimore, Maryland: Protocol for a Household Randomized Controlled Trial. JMIR Research Protocols. 2025. doi:10.2196/68600

BibTeX
@article{Duchen2025,
  author = {Duchen, Jessica and Mueller, Alexandra K and Ahmed, Saifuddin and Perin, Jamie and Borsuk, Courtney and Trowell, Joshua and Lowensen, Kelly and Huettner, Steven and Peytchev, Andy and Farley, Jason E and Mehta, Shruti H and Jennings, Jacky M},
  title = {Identifying Optimal Testing Modalities to Increase COVID-19 Testing Access in Baltimore, Maryland: Protocol for a Household Randomized Controlled Trial},
  journal = {JMIR Research Protocols},
  year = {2025},
  doi = {10.2196/68600}
}
Start for free →